Literature DB >> 31190253

Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy.

Marina Picillo1, Sofia Cuoco1, Marianna Amboni1, Francesco Paolo Bonifacio2, Antonino Bruno3, Fabio Bruschi4, Arianna Cappiello1, Rosa De Micco2, Anna De Rosa5, Francesca Di Biasio6, Francesca Elifani7, Roberto Erro1, Margherita Fabbri8, Marika Falla9,10, Giulia Franco11, Daniela Frosini3, Sebastiano Galantucci12, Giulia Lazzeri11, Luca Magistrelli13,14, Maria Chiara Malaguti15, Anna Vera Milner13, Brigida Minafra4, Enrica Olivola7, Andrea Pilotto16, Cristina Rascunà17, Maria Cristina Rizzetti18, Tommaso Schirinzi19, Barbara Borroni16, Roberto Ceravolo3, Alessio Di Fonzo11, Leonardo Lopiano8, Roberta Marchese6, Nicola B Mercuri19, Nicola Modugno7, Alessandra Nicoletti17, Alessandro Padovani16, Gabriella Santangelo20, Alessandro Stefani19, Alessandro Tessitore2, Maria Antonietta Volontè12, Roberta Zangaglia4, Mario Zappia17, Paolo Barone21.   

Abstract

Progressive supranuclear palsy (PSP) is a rare, rapidly progressive, neurodegenerative disease characterized by falls and ocular movement disturbances. Caring for a partner or relative who suffers from PSP entails a strenuous and demanding task, usually lasting for years that affects carers' everyday life routines and emotional and social well-being. The 26-item Parkinsonism Carers QoL (PQoL Carer) is a self-administered, concise instrument evaluating the quality of life of caregivers of patients with atypical parkinsonism (both PSP and multiple system atrophy). Here, the PQoL Carer was translated into Italian and validated in 162 carers of PSP patients (54.3% women; mean age (standard deviation), 62.4 (15.4)) diagnosed according to the Movement Disorder Society criteria and recruited in 16 third-level movement disorders centers participating in the Neurecanet project. The mean PQoL total score was 40.66 ± 19.46. The internal consistency was excellent (Cronbach's alpha = 0.941); corrected item-total correlation was > 0.40 for all the items. A correlation with other health-related quality of life measures as well as with behavioral assessments was shown suggesting adequate convergent validity of the scale. PQoL also correlated with patients' severity of disease. The discriminant validity of the scale was evidenced by its capacity to differentiate between carers with varying levels of self-reported health (p < 0.001). In conclusion, the Italian version of the PQoL Carer is an easy, consistent, and valid tool for the assessment of the quality of life in carers of PSP patients.

Entities:  

Keywords:  Caregiver; Carer; Clinical trials; Progressive supranuclear palsy; Quality of life

Mesh:

Year:  2019        PMID: 31190253     DOI: 10.1007/s10072-019-03944-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

Review 2.  Assessing health status and quality-of-life instruments: attributes and review criteria.

Authors:  Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

Review 3.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

4.  MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes.

Authors:  Marina Picillo; Roberto Erro; Sofia Cuoco; Maria Francesca Tepedino; Renzo Manara; Maria Teresa Pellecchia; Paolo Barone
Journal:  Mov Disord       Date:  2018-07-08       Impact factor: 10.338

Review 5.  Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear Palsy.

Authors:  Louise Wiblin; Mark Lee; David Burn
Journal:  Parkinsonism Relat Disord       Date:  2016-10-19       Impact factor: 4.891

6.  Rasch analysis of the carers quality of life questionnaire for parkinsonism.

Authors:  Marios Pillas; Caroline Selai; Anette Schrag
Journal:  Mov Disord       Date:  2016-11-22       Impact factor: 10.338

7.  A clinical rating scale for progressive supranuclear palsy.

Authors:  Lawrence I Golbe; Pamela A Ohman-Strickland
Journal:  Brain       Date:  2007-04-02       Impact factor: 13.501

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers).

Authors:  Marios Pillas; Caroline Selai; Niall P Quinn; Andrew Lees; Irene Litvan; Anthony Lang; James Bower; David Burn; Philip Low; Anette Schrag
Journal:  Qual Life Res       Date:  2015-08-12       Impact factor: 4.147

10.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

View more
  2 in total

1.  Validation of the Italian version of the PSP Quality of Life questionnaire.

Authors:  Marina Picillo; Sofia Cuoco; Marianna Amboni; Francesco Paolo Bonifacio; Fabio Bruschi; Immacolata Carotenuto; Rosa De Micco; Anna De Rosa; Eleonora Del Prete; Francesca Di Biasio; Francesca Elifani; Roberto Erro; Margherita Fabbri; Marika Falla; Giulia Franco; Daniela Frosini; Sebastiano Galantucci; Giulia Lazzeri; Luca Magistrelli; Maria Chiara Malaguti; Anna Vera Milner; Brigida Minafra; Enrica Olivola; Andrea Pilotto; Cristina Rascunà; Maria Cristina Rizzetti; Tommaso Schirinzi; Barbara Borroni; Roberto Ceravolo; Alessio Di Fonzo; Roberta Marchese; Nicola B Mercuri; Nicola Modugno; Alessandra Nicoletti; Alessandro Padovani; Gabriella Santangelo; Alessandro Stefani; Alessandro Tessitore; Maria Antonietta Volontè; Roberta Zangaglia; Mario Zappia; Maurizio Zibetti; Paolo Barone
Journal:  Neurol Sci       Date:  2019-07-26       Impact factor: 3.307

2.  Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy.

Authors:  Sofia Cuoco; Arianna Cappiello; Filomena Abate; Maria Francesca Tepedino; Roberto Erro; Giampiero Volpe; Maria Teresa Pellecchia; Paolo Barone; Marina Picillo
Journal:  Brain Behav       Date:  2021-09-07       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.